Barry, OppHub America Desk · · Source: yahoo-tickers-rotation
QuidelOrtho Podcast Highlights ADLM 2026 Advances
- QuidelOrtho Corporation (N: ) highlighted advancements in diagnostic technology during their latest podcast, potentially influencing investor sentiment around companies focused on rapid diagnostics and healthcare efficiency. - The discussion around Procalcitonin for antibiotic stewardship suggests potential implications for pharmaceutical and diagnostic companies involved in infection control and antibiotic development.
Based on reporting from yahoo-tickers-rotation.
QuidelOrtho Corporation (NASDAQ: QDEL) released episode 60 of its Science Bytes podcast, detailing advances from the ADLM 2026 conference. The episode discusses innovations in molecular diagnostics and cardiovascular assessments, aiming to provide clinicians with faster, actionable insights.
Market context for this story
As of: PremarketLoading quotes…
Informational only — not investment advice. Full markets →
$PCT
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/PCT and related $QDEL. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
QuidelOrtho Corporation (Nasdaq: $QDEL+WL) released episode 60 of its Science Bytes podcast, focusing on insights from the 2026 Association for Diagnostics and Laboratory Medicine (ADLM) Annual Conference. The episode highlights advancements in diagnostic solutions, including ultra-fast RT-PCR technology, simplified workflow expansions, and the use of Procalcitonin (PCT) for antibiotic stewardship.
Discussions centered on how innovations in molecular diagnostics, infectious disease management, and cardiovascular care can provide clinicians with rapid, actionable information. Featured guests included experts from LEX Diagnostics and Thermo Fisher Scientific, alongside QuidelOrtho's Medical Affairs Manager. These advancements aim to support confident decision-making and improve patient outcomes by accelerating diagnostic results and assessments.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
- QuidelOrtho Corporation (N: ) highlighted advancements in diagnostic t
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 27, 2026 at 10:46 AM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
diagnostic technology
A medical company shared new updates about faster disease testing tools, which can create interest in companies that make medical equipment. Beginners care because new health technology often drives business growth for the companies involved.
What changed
QuidelOrtho released podcast episode 60 detailing ADLM 2026 diagnostic advances in molecular testing and infection control.
Who wins / who loses
Diagnostic technology providers benefit from clinical efficiency trends, while laggards in molecular testing risk losing competitive ground.
Time horizon
Think in terms of the next few weeks.
Confidence & best fit
medium confidence · Long-term investor
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $QDELWatch — track, don’t rush
QuidelOrtho is talking up its new testing tools, which could attract positive attention from investors.
View $QDEL chart → · End-of-day delayed data
Peer
- $TMOWatch — track, don’t rush
Thermo Fisher was mentioned on the podcast for its work in medical testing, tying its stock to these new health tech trends.
View $TMO chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Beginners should skip options here because the podcast news is general product information rather than an immediate financial event.
See options-friendly brokers →Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Look into local healthcare systems adopting rapid diagnostic workflows to improve patient turnaround times.
What would break this thesis
- Slower-than-expected commercial adoption of the highlighted diagnostic technologies or broader healthcare sector downturns.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-rotation.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).